Report Detail

Other Global Insulin Delivery Devices Market Professional Survey Report 2019

  • RnM3743357
  • |
  • 13 September, 2019
  • |
  • Global
  • |
  • 114 pages
  • |
  • QYResearch
  • |
  • Other

Global Insulin Delivery Devices Market Professional Survey Report 2019

Table of Contents

    Executive Summary

      1 Industry Overview of Insulin Delivery Devices

      • 1.1 Definition of Insulin Delivery Devices
      • 1.2 Insulin Delivery Devices Segment by Type
        • 1.2.1 Global Insulin Delivery Devices Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Insulin Pens
        • 1.2.3 Insulin Pumps
        • 1.2.4 Insulin Syringes
        • 1.2.5 Others
      • 1.3 Insulin Delivery Devices Segment by Applications
        • 1.3.1 Global Insulin Delivery Devices Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Patients/Homecare
        • 1.3.3 Hospitals & Clinics
      • 1.4 Global Insulin Delivery Devices Overall Market
        • 1.4.1 Global Insulin Delivery Devices Revenue (2014-2025)
        • 1.4.2 Global Insulin Delivery Devices Production (2014-2025)
        • 1.4.3 North America Insulin Delivery Devices Status and Prospect (2014-2025)
        • 1.4.4 Europe Insulin Delivery Devices Status and Prospect (2014-2025)
        • 1.4.5 China Insulin Delivery Devices Status and Prospect (2014-2025)
        • 1.4.6 Japan Insulin Delivery Devices Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Insulin Delivery Devices Status and Prospect (2014-2025)
        • 1.4.8 India Insulin Delivery Devices Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Insulin Delivery Devices
      • 2.3 Manufacturing Process Analysis of Insulin Delivery Devices
      • 2.4 Industry Chain Structure of Insulin Delivery Devices

      3 Development and Manufacturing Plants Analysis of Insulin Delivery Devices

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Insulin Delivery Devices Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Insulin Delivery Devices
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Insulin Delivery Devices Production and Capacity Analysis
      • 4.2 Insulin Delivery Devices Revenue Analysis
      • 4.3 Insulin Delivery Devices Price Analysis
      • 4.4 Market Concentration Degree

      5 Insulin Delivery Devices Regional Market Analysis

      • 5.1 Insulin Delivery Devices Production by Regions
        • 5.1.1 Global Insulin Delivery Devices Production by Regions
        • 5.1.2 Global Insulin Delivery Devices Revenue by Regions
      • 5.2 Insulin Delivery Devices Consumption by Regions
      • 5.3 North America Insulin Delivery Devices Market Analysis
        • 5.3.1 North America Insulin Delivery Devices Production
        • 5.3.2 North America Insulin Delivery Devices Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Insulin Delivery Devices Import and Export
      • 5.4 Europe Insulin Delivery Devices Market Analysis
        • 5.4.1 Europe Insulin Delivery Devices Production
        • 5.4.2 Europe Insulin Delivery Devices Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Insulin Delivery Devices Import and Export
      • 5.5 China Insulin Delivery Devices Market Analysis
        • 5.5.1 China Insulin Delivery Devices Production
        • 5.5.2 China Insulin Delivery Devices Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Insulin Delivery Devices Import and Export
      • 5.6 Japan Insulin Delivery Devices Market Analysis
        • 5.6.1 Japan Insulin Delivery Devices Production
        • 5.6.2 Japan Insulin Delivery Devices Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Insulin Delivery Devices Import and Export
      • 5.7 Southeast Asia Insulin Delivery Devices Market Analysis
        • 5.7.1 Southeast Asia Insulin Delivery Devices Production
        • 5.7.2 Southeast Asia Insulin Delivery Devices Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Insulin Delivery Devices Import and Export
      • 5.8 India Insulin Delivery Devices Market Analysis
        • 5.8.1 India Insulin Delivery Devices Production
        • 5.8.2 India Insulin Delivery Devices Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Insulin Delivery Devices Import and Export

      6 Insulin Delivery Devices Segment Market Analysis (by Type)

      • 6.1 Global Insulin Delivery Devices Production by Type
      • 6.2 Global Insulin Delivery Devices Revenue by Type
      • 6.3 Insulin Delivery Devices Price by Type

      7 Insulin Delivery Devices Segment Market Analysis (by Application)

      • 7.1 Global Insulin Delivery Devices Consumption by Application
      • 7.2 Global Insulin Delivery Devices Consumption Market Share by Application (2014-2019)

      8 Insulin Delivery Devices Major Manufacturers Analysis

      • 8.1 Novo Nordisk
        • 8.1.1 Novo Nordisk Insulin Delivery Devices Production Sites and Area Served
        • 8.1.2 Novo Nordisk Product Introduction, Application and Specification
        • 8.1.3 Novo Nordisk Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Sanofi
        • 8.2.1 Sanofi Insulin Delivery Devices Production Sites and Area Served
        • 8.2.2 Sanofi Product Introduction, Application and Specification
        • 8.2.3 Sanofi Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 BD
        • 8.3.1 BD Insulin Delivery Devices Production Sites and Area Served
        • 8.3.2 BD Product Introduction, Application and Specification
        • 8.3.3 BD Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Eli Lilly
        • 8.4.1 Eli Lilly Insulin Delivery Devices Production Sites and Area Served
        • 8.4.2 Eli Lilly Product Introduction, Application and Specification
        • 8.4.3 Eli Lilly Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Medtronic
        • 8.5.1 Medtronic Insulin Delivery Devices Production Sites and Area Served
        • 8.5.2 Medtronic Product Introduction, Application and Specification
        • 8.5.3 Medtronic Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Animas
        • 8.6.1 Animas Insulin Delivery Devices Production Sites and Area Served
        • 8.6.2 Animas Product Introduction, Application and Specification
        • 8.6.3 Animas Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Beta Bionics
        • 8.7.1 Beta Bionics Insulin Delivery Devices Production Sites and Area Served
        • 8.7.2 Beta Bionics Product Introduction, Application and Specification
        • 8.7.3 Beta Bionics Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Cellnovo
        • 8.8.1 Cellnovo Insulin Delivery Devices Production Sites and Area Served
        • 8.8.2 Cellnovo Product Introduction, Application and Specification
        • 8.8.3 Cellnovo Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Copernicus
        • 8.9.1 Copernicus Insulin Delivery Devices Production Sites and Area Served
        • 8.9.2 Copernicus Product Introduction, Application and Specification
        • 8.9.3 Copernicus Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Dance Biopharm
        • 8.10.1 Dance Biopharm Insulin Delivery Devices Production Sites and Area Served
        • 8.10.2 Dance Biopharm Product Introduction, Application and Specification
        • 8.10.3 Dance Biopharm Insulin Delivery Devices Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Debiotech
      • 8.12 Insulet
      • 8.13 MannKind
      • 8.14 Owen Mumford
      • 8.15 Roche
      • 8.16 SOOIL
      • 8.17 Tandem Diabetes Care
      • 8.18 Valeritas
      • 8.19 West Pharma
      • 8.20 Ypsomed

      9 Development Trend of Analysis of Insulin Delivery Devices Market

      • 9.1 Global Insulin Delivery Devices Market Trend Analysis
        • 9.1.1 Global Insulin Delivery Devices Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Insulin Delivery Devices Regional Market Trend
        • 9.2.1 North America Insulin Delivery Devices Forecast 2019-2025
        • 9.2.2 Europe Insulin Delivery Devices Forecast 2019-2025
        • 9.2.3 China Insulin Delivery Devices Forecast 2019-2025
        • 9.2.4 Japan Insulin Delivery Devices Forecast 2019-2025
        • 9.2.5 Southeast Asia Insulin Delivery Devices Forecast 2019-2025
        • 9.2.6 India Insulin Delivery Devices Forecast 2019-2025
      • 9.3 Insulin Delivery Devices Market Trend (Product Type)
      • 9.4 Insulin Delivery Devices Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Insulin Delivery Devices Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Insulin Delivery Devices include syringes, pens, pumps, and others. The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.

        In 2017, the insulin pens segment accounted for the largest share of the global insulin delivery devices market. The insulin pens segment is further divided into reusable pens and disposable pens.
        On the basis of end user, the patients/homecare segment commanded the largest share of the insulin delivery devices market in 2017, and is expected to grow at the highest CAGR during the forecast period.
        In 2017, North America accounted for the largest share of the global insulin delivery devices market. The large share of this segment can be attributed to the rising prevalence of diabetes and favorable reimbursement scenario in the U.S. and Canada, growing venture capital investments and issuance of IPOs in the U.S., and FDA approvals to increase the commercial availability of insulin delivery devices in the U.S.

        The global Insulin Delivery Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Insulin Delivery Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Delivery Devices market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Delivery Devices in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Insulin Delivery Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Novo Nordisk
        Sanofi
        BD
        Eli Lilly
        Medtronic
        Animas
        Beta Bionics
        Cellnovo
        Copernicus
        Dance Biopharm
        Debiotech
        Insulet
        MannKind
        Owen Mumford
        Roche
        SOOIL
        Tandem Diabetes Care
        Valeritas
        West Pharma
        Ypsomed

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Insulin Pens
        Insulin Pumps
        Insulin Syringes
        Others

        Segment by Application
        Patients/Homecare
        Hospitals & Clinics


        Summary:
        Get latest Market Research Reports on Insulin Delivery Devices. Industry analysis & Market Report on Insulin Delivery Devices is a syndicated market report, published as Global Insulin Delivery Devices Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Insulin Delivery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,801.03
        4,201.54
        5,602.05
        3,172.18
        4,758.26
        6,344.35
        377,590.50
        566,385.75
        755,181.00
        248,793.30
        373,189.95
        497,586.60
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report